Shuhei Matsumoto

<i>In Vitro</i> Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria

Akinobu Ito, Takafumi Sato, Merime Ota et al. · Antimicrobial Agents and Chemotherapy · 2017 · 378 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa

Akinobu Ito, Toru Nishikawa, Shuhei Matsumoto et al. · Antimicrobial Agents and Chemotherapy · 2016 · 333 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study

John G. Laffey, Fabiana Madotto, Giacomo Bellani et al. · The Lancet Respiratory Medicine · 2017 · 126 citations · Full text

Medicine, Health Sciences, Cost-effectiveness Analysis +11

<i>In Vivo</i> Pharmacodynamic Study of Cefiderocol, a Novel Parenteral Siderophore Cephalosporin, in Murine Thigh and Lung Infection Models

Rio Nakamura, Tsukasa Ito-Horiyama, Miki Takemura et al. · Antimicrobial Agents and Chemotherapy · 2019 · 111 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics

Shuhei Matsumoto, Christine M. Singley, Jennifer L. Hoover et al. · Antimicrobial Agents and Chemotherapy · 2017 · 101 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12